Anfield Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-185
Closed -$38K 93
2022
Q4
$38K Buy
+185
New +$46.8K 0.02% 76

Other funds holding SWAV

Anfield Capital Management's SWAV Position: Q1 2023 in Review

Anfield Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 185 shares — an estimated $38K sold.

Anfield Capital Management first reported a position in SWAV in Q4 2022 and held it in 1 quarter. The position peaked at $38K in Q4 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • Anfield Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Anfield Capital Management sold 185 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $38K.
  • Anfield Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Anfield Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $38K in Q4 2022.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Anfield Capital Management's 13F filing for Q1 2023, filed 4 May 2023.